Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
178.30B
Market cap178.30B
Price-Earnings ratio
32.95
Price-Earnings ratio32.95
Dividend yield
2.43%
Dividend yield2.43%
Average volume
8.04M
Average volume8.04M
High today
$104.44
High today$104.44
Low today
$102.57
Low today$102.57
Open price
$104.00
Open price$104.00
Volume
3.42M
Volume3.42M
52 Week high
$137.49
52 Week high$137.49
52 Week low
$81.97
52 Week low$81.97

Stock Snapshot

Abbott(ABT) stock is priced at $103.04, giving the company a market capitalization of 178.3B. It carries a P/E multiple of 32.95 and pays a dividend yield of 2.43%.

As of 2026-09-14, Abbott(ABT) stock has fluctuated between $102.57 and $104.44. The current price stands at $103.04, placing the stock +0.5% above today's low and -1.3% off the high.

Abbott(ABT) shares are trading with a volume of 3.42M, against a daily average of 8.04M.

In the last year, Abbott(ABT) shares hit a 52-week high of $137.49 and a 52-week low of $81.97.

In the last year, Abbott(ABT) shares hit a 52-week high of $137.49 and a 52-week low of $81.97.

ABT News

Investing.com 2h
Abbott to pay $384 million over contaminated infant formula allegations, US Justice Dept says By Reuters - Investing.com

...

Abbott to pay $384 million over contaminated infant formula allegations, US Justice Dept says By Reuters - Investing.com
TipRanks 3h
Abbott confirms agreement with DOJ to resolve 2022 formula recall claims

Abbott (ABT) confirmed the company has reached an agreement to resolve the previously disclosed investigation and lawsuit brought by the United States Departmen...

TipRanks 3h
Abbott to pay over $384M to settle infant formula allegations

Abbott (ABT) Laboratories has agreed to pay $384,999,040 to resolve allegations that it caused false claims to be submitted between Jan. 1, 2018, and Dec. 31, 2...

Analyst ratings

79%

of 29 ratings
Buy
79.3%
Hold
20.7%
Sell
0%

More ABT News

Nasdaq 6d
Abbott Laboratories Breaks Below 200-Day Moving Average - Notable for ABT

In trading on Thursday, shares of Abbott Laboratories (Symbol: ABT) crossed below their 200 day moving average of $125.06, changing hands as low as $120.20 per...

Abbott Laboratories Breaks Below 200-Day Moving Average - Notable for ABT
TipRanks 6d
Abbott’s TactiFlex Duo Ablation Catheter approved by FDA

Abbott (ABT) has received FDA approval for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat patients with challenging cases of atrial fibrillation,...

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.